Evidence map›Paper›PMID 40062171›Full record

ArticleCureus2025

Exploring the Enigma of a Urachal Mucinous Cystic Tumor of Low Malignant Potential (MCTLMP): A Case Report and Literature Review.

Klaas De Corte, Ali Ramadhan

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Klaas De CorteDepartment of Pathology, Antwerp University Hospital, Edegem, BEL.
Ali RamadhanDepartment of Pathology, Antwerp University Hospital, Edegem, BEL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucinous urachal neoplasms are rare and can present as benign cystadenomas, mucinous cystic tumors of low malignant potential (MCTLMPs), or invasive adenocarcinomas. MCTLMPs occupy a borderline category characterized by mild-to-moderate atypia and papillary/villous architecture without stromal invasion. Here, we describe a 54-year-old male patient who presented with persistent dysuria and was found to have a vesicourachal diverticulum. Surgical management involved a robot-assisted partial cystectomy with complete excision of the urachal remnant. Histopathologic examination revealed a multiloculated cystic lesion lined by mucin-producing epithelium, confirming an MCTLMP; immunohistochemical staining demonstrated intestinal differentiation (CK20+/CK7-/CDX2+) and absence of invasive features. p53 demonstrated wild-type expression, indicating no significant molecular alterations. The early postoperative course was uneventful, with no complications such as infection or urinary leakage. At the one-year follow-up, the patient experienced persistent urinary urgency, suprapubic discomfort, and scrotal pain, indicative of lower urinary tract dysfunction secondary to surgical intervention. No recurrence has been observed. This case underscores the importance of accurate histopathological evaluation, complete surgical resection, and vigilant long-term surveillance to prevent progression of urachal mucinous tumors. Further research into molecular markers may refine prognostication and guide future therapeutic strategies for these rare neoplasms.

Indexed as

adenocarcinomahistopathologyimmunohistochemistry stainingkras mutationslow malignant potentialmucinous cystic tumorpseudomyxoma peritoneiurachal neoplasmsurachusvesicourachal diverticulum

Identifiers

PMID40062171
PMCPMC11888570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.